Thanks to technological advancements in nucleic acid sequencing and the shift toward molecular research and personalized medicine, omics approaches have become increasingly important in studying the mechanisms of virulence and resistance employed by microorganisms. Omics sciences are especially crucial, as the rise of multi-drug resistant pathogens continues to challenge existing therapeutic strategies, underscoring the need for more comprehensive studies and innovative approaches.
This Research Topic aims to explore the potential of omics technologies to revolutionize the study of infectious diseases. We seek to gather high-quality scientific papers that clearly demonstrate the use of omics approaches in clinical microbiology studies or that support the treatment of infectious diseases.
To gather further insights, we welcome original articles, reviews and brief research report addressing, but not limited to, topics such as:
• the epidemiology and molecular study of antimicrobial resistance,
• dynamics of host-parasite interactions,
• emergence of new virulence gene variants,
• the emergence of novel sequence types (STs) and the development of new clones
• plasmid transfer in pathogenic microorganisms,
• studies characterizing mechanisms of action and resistance, as well as responses to both established and novel antimicrobials (such as fosfomycin, cefiderocol, or meropenem-vaborbactam), and
• studies employing Next-Generation Sequencing (NGS) techniques such as whole genome sequencing and RNA sequencing
This Research Topic aspires to provide a detailed picture of how omics technologies are reshaping our understanding of infectious diseases, with the potential to inform more effective interventions and innovative treatment options.
Keywords:
Genomic; Transcriptomic; Proteomic; NGS; Microorganisms; Infectious diseases
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Thanks to technological advancements in nucleic acid sequencing and the shift toward molecular research and personalized medicine, omics approaches have become increasingly important in studying the mechanisms of virulence and resistance employed by microorganisms. Omics sciences are especially crucial, as the rise of multi-drug resistant pathogens continues to challenge existing therapeutic strategies, underscoring the need for more comprehensive studies and innovative approaches.
This Research Topic aims to explore the potential of omics technologies to revolutionize the study of infectious diseases. We seek to gather high-quality scientific papers that clearly demonstrate the use of omics approaches in clinical microbiology studies or that support the treatment of infectious diseases.
To gather further insights, we welcome original articles, reviews and brief research report addressing, but not limited to, topics such as:
• the epidemiology and molecular study of antimicrobial resistance,
• dynamics of host-parasite interactions,
• emergence of new virulence gene variants,
• the emergence of novel sequence types (STs) and the development of new clones
• plasmid transfer in pathogenic microorganisms,
• studies characterizing mechanisms of action and resistance, as well as responses to both established and novel antimicrobials (such as fosfomycin, cefiderocol, or meropenem-vaborbactam), and
• studies employing Next-Generation Sequencing (NGS) techniques such as whole genome sequencing and RNA sequencing
This Research Topic aspires to provide a detailed picture of how omics technologies are reshaping our understanding of infectious diseases, with the potential to inform more effective interventions and innovative treatment options.
Keywords:
Genomic; Transcriptomic; Proteomic; NGS; Microorganisms; Infectious diseases
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.